title: Prostacyclin reverses the cigarette smoke-induced decrease in pulmonary Frizzled 9 expression through miR-31.
abstract: Half of lung cancers are diagnosed in former smokers, leading to a significant treatment burden in this population. Chemoprevention in former smokers using the prostacyclin analogue iloprost reduces endobronchial dysplasia, a premalignant lung lesion. Iloprost requires the presence of the WNT receptor Frizzled 9 (Fzd9) for inhibition of transformed growth in vitro. To investigate the relationship between iloprost, cigarette smoke, and Fzd9 expression, we used human samples, mouse models, and in vitro studies. Fzd9 expression was low in human lung tumors and in progressive dysplasias. In mouse models and in vitro studies, tobacco smoke carcinogens reduced expression of Fzd9 while prostacyclin maintained or increased expression. Expression of miR-31 repressed Fzd9 expression, which was abrogated by prostacyclin. We propose a model where cigarette smoke exposure increases miR-31 expression, which leads to decreased Fzd9 expression and prevents response to iloprost. When smoke is removed miR-31 is reduced, prostacyclin can increase Fzd9 expression, and progression of dysplasia is inhibited. Fzd9 and miR-31 are candidate biomarkers for precision application of iloprost and monitoring of treatment progress. As we continue to investigate the mechanisms of prostacyclin chemoprevention and identify biomarkers for its use, we will facilitate clinical trials and speed implementation of this valuable prevention approach.
authors.affiliation: University of Colorado Denver, Aurora, Colorado, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Tennis
authors.affiliation: University of Colorado Denver, Aurora, Colorado, USA.
authors.forename: M L
authors.initials: ML
authors.lastname: New
authors.affiliation: Denver Veterans Administration Medical Center, Denver, Colorado, USA.
authors.forename: D G
authors.initials: DG
authors.lastname: McArthur
authors.affiliation: University of Colorado Denver, Aurora, Colorado, USA.
authors.forename: D T
authors.initials: DT
authors.lastname: Merrick
authors.affiliation: University of Colorado Denver, Aurora, Colorado, USA.
authors.forename: L D
authors.initials: LD
authors.lastname: Dwyer-Nield
authors.affiliation: University of Colorado Denver, Aurora, Colorado, USA.|Denver Veterans Administration Medical Center, Denver, Colorado, USA.
authors.forename: R L
authors.initials: RL
authors.lastname: Keith
mesh_terms: D000818:Animals; D001980:Bronchi / Q000166:cytology; D002478:Cells, Cultured; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D011464:Epoprostenol / Q000494:pharmacology*; D051157:Frizzled Receptors / Q000235:genetics / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D016285:Iloprost / Q000494:pharmacology; D008175:Lung Neoplasms / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D035683:MicroRNAs / Q000235:genetics / Q000378:metabolism*; D012906:Smoke / Q000009:adverse effects*; D014520:Urethane / Q000633:toxicity
chemical_list: D051157:Frizzled Receptors; D035683:MicroRNAs; D012906:Smoke; D014520:Urethane; D011464:Epoprostenol; D016285:Iloprost